drugset / Trial / NCT02062749

Escalating Doses of Oxaliplatin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Children and Adolescents With Extensive Colon Carcinoma

NCT02062749 ↗

Phase 1 Completed 1 enrolled M.D. Anderson Cancer Center
NaSingle-groupOpen-labelTreatment

Summary

The goal of this clinical research study is to find the highest tolerated dose of heated intra-abdominal oxaliplatin that can be given to patients with colon cancer. Researchers also want to learn more about the ways that pediatric and young adult colon cancer may be different from colon cancer in adults.

Timeline

Start
2014-05-19
Primary completion
2018-06-27
Completion
2018-06-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxaliplatin Small molecule 175 mg/m2 Other

Indications